C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis

被引:27
作者
Ishida, Natsuki [1 ]
Higuchi, Tomohiro [1 ]
Miyazu, Takahiro [1 ]
Tamura, Satoshi [1 ]
Tani, Shinya [1 ]
Yamade, Mihoko [1 ]
Iwaizumi, Moriya [2 ]
Hamaya, Yasushi [1 ]
Osawa, Satoshi [3 ]
Furuta, Takahisa [4 ]
Sugimoto, Ken [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Dept Lab Med, Higashi Ku, I-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan
[3] Hamamatsu Univ Sch Med, Dept Endoscop & Photodynam Med, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ Sch Med, Clin Res Ctr, Hamamatsu, Shizuoka, Japan
关键词
BOWEL-DISEASE; ENDOSCOPIC ACTIVITY; IMMUNOCHEMICAL TEST; BLOOD BIOMARKERS; CALPROTECTIN; SEVERITY; INDEX; HEMOGLOBIN; THERAPY; MARKERS;
D O I
10.1038/s41598-021-90558-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We evaluated the association between endoscopic scores of colonic inflammation and fecal calprotectin (FC), fecal immunochemical occult blood test (FIT), and C-reactive protein (CRP) in patients with ulcerative colitis (UC). Endoscopic scores reflecting the most severe lesion [maximum Mayo Endoscopic Subscore (M-MES) and Ulcerative Colitis Endoscopic Index of Severity (UCEIS)] and those reflecting the inflammation of the entire colon [sum of MES (S-MES) and Ulcerative Colitis Colonoscopic Index of Severity (UCCIS)] were evaluated. FC, FIT, and CRP were measured, and their association with the four endoscopic scores was evaluated. Endoscopic scores of 78 complete colonoscopies (66 UC patients) were evaluated using the three biomarkers. FC and CRP tended to correlate more strongly with S-MES and UCCIS than with M-MES and UCEIS. In the M-MES 0, 1 group, compared to CRP, FC and FIT showed stronger correlations with S-MES and UCCIS. Conversely, in the M-MES 2, 3 group, only CRP was significantly correlated with each descriptor. CRP more strongly reflects colon-wide mucosal inflammation than FC and allows reliable assessment of inflammation throughout the colon in active UC.
引用
收藏
页数:8
相关论文
共 31 条
[1]   Colonoscopic perforations in inflammatory bowel disease: A retrospective study in a French referral centre [J].
Buissona, Anthony ;
Chevaux, Jean-Baptiste ;
Hudziak, Herve ;
Bresler, Laurent ;
Bigard, Marc-Andre ;
Peyrin-Biroulet, Laurent .
DIGESTIVE AND LIVER DISEASE, 2013, 45 (07) :569-572
[2]   Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis [J].
Colombel, Jean Frederic ;
Rutgeerts, Paul ;
Reinisch, Walter ;
Esser, Dirk ;
Wang, Yanxin ;
Lang, Yinghua ;
Marano, Colleen W. ;
Strauss, Richard ;
Oddens, Bjoern J. ;
Feagan, Brian G. ;
Hanauer, Stephen B. ;
Lichtenstein, Gary R. ;
Present, Daniel ;
Sands, Bruce E. ;
Sandborn, William J. .
GASTROENTEROLOGY, 2011, 141 (04) :1194-1201
[3]   A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis [J].
D'Haens, Geert ;
Sandborn, William J. ;
Feagan, Brian G. ;
Geboes, Karel ;
Hanauer, Stephen B. ;
Irvine, E. Jan ;
Lemann, Marc ;
Marteau, Philippe ;
Rutgeerts, Paul ;
Scholmerich, Jurgen ;
Sutherland, Lloyd R. .
GASTROENTEROLOGY, 2007, 132 (02) :763-786
[4]   Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease [J].
D'Haens, Geert ;
Ferrante, Marc ;
Vermeire, Severine ;
Baert, Filip ;
Noman, Maja ;
Moortgat, Liesbeth ;
Geens, Patricia ;
Iwens, Doreen ;
Aerden, Isolde ;
Van Assche, Gert ;
Van Olmen, Gust ;
Rutgeerts, Paul .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (12) :2218-2224
[5]   C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study [J].
Henriksen, M. ;
Jahnsen, J. ;
Lygren, I. ;
Stray, N. ;
Sauar, J. ;
Vatn, M. H. ;
Moum, B. .
GUT, 2008, 57 (11) :1518-1523
[6]   Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis [J].
Hiraoka, Sakiko ;
Inokuchi, Toshihiro ;
Nakarai, Asuka ;
Takashima, Shiho ;
Takei, Daisuke ;
Sugihara, Yuusaku ;
Takahara, Masahiro ;
Harada, Keita ;
Okada, Hiroyuki ;
Kato, Jun .
GUT AND LIVER, 2018, 12 (02) :142-148
[7]   Correlation of C-Reactive Protein with Clinical and Endoscopic Activity in Patients with Ulcerative Colitis [J].
Karoui, Sami ;
Laz, Sonia ;
Serghini, Meriem ;
Bibani, Norsaf ;
Boubaker, Jalel ;
Filali, Azza .
DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (06) :1801-1805
[8]   Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis [J].
Kawashima, Kousaku ;
Ishihara, Shunji ;
Yuki, Takafumi ;
Fukuba, Nobuhiko ;
Oshima, Naoki ;
Kazumori, Hideaki ;
Sonoyama, Hiroki ;
Yamashita, Noritsugu ;
Tada, Yasumasa ;
Kusunoki, Ryusaku ;
Oka, Akihiko ;
Mishima, Yoshiyuki ;
Moriyama, Ichiro ;
Kinoshita, Yoshikazu .
BMC GASTROENTEROLOGY, 2016, 16
[9]   PRELIMINARY-REPORT - CYCLOSPORINE IN TREATMENT OF SEVERE ACTIVE ULCERATIVE-COLITIS [J].
LICHTIGER, S ;
PRESENT, DH .
LANCET, 1990, 336 (8706) :16-19
[10]   The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients [J].
Lobaton, Triana ;
Bessissow, Talat ;
De Hertogh, Gert ;
Lemmens, Bart ;
Maedler, Chelsea ;
Van Assche, Gert ;
Vermeire, Severine ;
Bisschops, Raf ;
Rutgeerts, Paul ;
Bitton, Alain ;
Afif, Waqqas ;
Marcus, Victoria ;
Ferrante, Marc .
JOURNAL OF CROHNS & COLITIS, 2015, 9 (10) :846-852